CTSI appoints Dileep Mangsuli as Chairman to lead South Asia strategy

Cancer Treatment Services International (CTSI) has appointed Dileep Mangsuli as Chairman to lead its South Asia network. Mangsuli will continue in his current role as Senior Vice President at Siemens Healthineers while taking on this strategic position at CTSI.

Mangsuli’s professional background spans over two decades in the healthcare technology sector. At Siemens Healthineers, he has led key initiatives involving artificial intelligence, digital twins, and immersive technologies aimed at improving diagnostic accuracy and patient care. He has also played a role in collaborative projects, including the AI in Precision Medicine Lab at the Indian Institute of Science, which focuses on developing open-source AI tools for neuroimaging.

As Chairman at CTSI-South Asia, Mangsuli will be responsible for setting the strategic direction and ensuring operational effectiveness across the organisation’s regional network. This includes the American Oncology Institute, Citizens Specialty Hospital, and Ampath Labs.

His appointment is aligned with CTSI’s broader goal of integrating digital healthcare technologies to support improved cancer care and patient outcomes in South Asia.

Dileep Mangsuli, Chairman, CTSI-South Asia, said, “I am pleased to join CTSI at such a transformative phase in its journey. The industry is witnessing a profound transformation, driven by the need for strategic, results-focused solutions that enhance operational efficiency and accelerate digital adoption. CTSI’s dedication to integrating advanced technology with clinical excellence places it at the forefront of transforming healthcare in South Asia. I am excited to bring my experience in digital healthcare to support the organisation’s strategic growth and enhance access to high-quality healthcare across the region. Alongside the team, I remain committed to setting new standards in clinical outcomes and patient at the core of everything we do.”

CTSI’s focus on digital transformation in oncology and specialty care is part of its approach to building scalable healthcare models for the region. With this leadership change, the organisation is expected to advance its goals of improving access, enhancing care delivery, and strengthening outcomes in cancer and related healthcare services.